SEC Form 4 · accession 0000950138-17-000487
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kathy A Schaefer
Officer — Sr. VP & Corp. Controller
Period of report
Jun 9, 2017
Accepted (ET)
Jun 13, 2017 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Jun 9, 2017 | M | 2,000 | $31.23 | A | 17,151 | D | |
| Ordinary Shares | Jun 9, 2017 | F | 1,723 | $39.72 | D | 15,428 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Options (Right to Buy) | $31.23 | Jun 9, 2017 | M | 2,000 | D | Jun 28, 2013 | Jul 1, 2017 | Ordinary Shares | 2,000 | 0 | D |
Explanation of responses
- F1Includes 135 shares acquired between December 31, 2016 and March 31, 2017 under the Mallinckrodt employee stock purchase plan.